Skip to main content

Maze Therapeutics, Inc.

MAZE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001842295

In the last 90 days, Maze Therapeutics, Inc. insiders filed 0 open-market purchases and 14 sales; 161 institutions reported holding it in 13F filings for Q2 2026, worth $1.75B in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Maze Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
14 filings
4 insiders, $6.19M in total
Insiders trading
4
Net value
−$6.19M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Maze Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Maze Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Bernstein HaroldPresident, R&D & CMO0Sep 8, 202615
Courtney PhillipsGC and Corp. Secretary7,007Sep 4, 20263
Dandekar AtulCSBO32,316Sep 4, 202612
Coloma Jason VChief Executive Officer27,362Sep 4, 20269
Kornowski SophieDirector–Aug 17, 20261
Johnson Paula ADirector–Aug 17, 20261
Homcy Charles JDirector31,113Jun 10, 20264
Scheller Richard HDirector0Jun 10, 20261
Spiegelman Daniel KDirector–Jun 10, 20261
Lim Jonathan EDirector307,956IndirectJun 10, 20261
Hoppenot HerveDirector–Jun 10, 20262
Andrews Nancy CDirector–Jun 10, 20261
Bachrodt AmySVP, Finance12,965Apr 2, 20266
Kumar NeilDirector–Mar 31, 20261
Tahir MisbahChief Financial Officer–Mar 3, 20261
Sohn Catherine A.Director0Jan 8, 20261
TRV GP IV, LLC10% Owner4,473,958Nov 5, 20251
Third Rock Ventures GP IV, L.P.10% Owner4,473,958Nov 5, 20251
Third Rock Ventures IV, L.P.10% Owner4,473,958Nov 5, 20251
Third Rock Ventures V, L.P.10% Owner4,473,958Nov 5, 20251
Third Rock Ventures GP V, LP10% Owner4,473,958Nov 5, 20251
TRV GP V, LLC10% Owner4,473,958Nov 5, 20251
Exter NeilDirector–Sep 24, 20250
Kathiresan SekarDirector–Sep 24, 20250

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 8, 2026 (view filing)4:20 PM ETSep 44 daysBernstein HaroldPresident, R&D & CMOSSale−9.71K$26.22−$254.5K−100.0%0 after10b5-1
Sep 4, 2026 (view filing)4:27 PM ETSep 2-32 daysCourtney PhillipsGC and Corp. SecretarySSale−3.99K$26.24−$104.8K−36.3%7.01K after4 lots
Sep 4, 2026 (view filing)4:25 PM ETSep 2-32 daysDandekar AtulCSBOSSale−6.43K$26.24−$168.8K−16.6%32.3K after4 lots
Sep 4, 2026 (view filing)4:24 PM ETSep 2-32 daysColoma Jason VChief Executive OfficerSSale−22.6K$26.24−$594.0K−45.3%27.4K after4 lots
Sep 4, 2026 (view filing)4:22 PM ETSep 2-32 daysBernstein HaroldPresident, R&D & CMOSSale−10.3K$26.24−$270.1K−51.5%9.71K after4 lots
Sep 3, 2026 (view filing)4:27 PM ETSep 12 daysColoma Jason VChief Executive OfficerSSale−34.5K$26.29−$907.0K−13.4%223.4K after2 lots10b5-1
Sep 3, 2026 (view filing)4:24 PM ETSep 12 daysBernstein HaroldPresident, R&D & CMOSSale−16.1K$26.36−$425.5K−100.0%0 after10b5-1
Aug 31, 2026 (view filing)6:32 PM ETAug 283 daysDandekar AtulCSBOSSale−7.50K$27.58−$206.8K−22.2%26.3K after10b5-1
Aug 14, 2026 (view filing)4:54 PM ETAug 131 dayBernstein HaroldPresident, R&D & CMOSSale−16.1K$27.61−$445.6K−100.0%0 after10b5-1
Aug 5, 2026 (view filing)4:08 PM ETAug 32 daysColoma Jason VChief Executive OfficerSSale−34.5K$26.73−$922.3K−11.9%255.3K after4 lots10b5-1
Jul 31, 2026 (view filing)4:15 PM ETJul 292 daysDandekar AtulCSBOSSale−7.50K$27.34−$205.0K−22.2%26.3K after2 lots10b5-1
Jul 2, 2026 (view filing)4:29 PM ETJul 11 dayBernstein HaroldPresident, R&D & CMOSSale−14.6K$29.90−$436.9K−100.0%0 after2 lots10b5-1
Jul 2, 2026 (view filing)4:28 PM ETJul 11 dayColoma Jason VChief Executive OfficerSSale−34.5K$29.98−$1.03M−10.7%287.2K after3 lots10b5-1
Jul 1, 2026 (view filing)4:17 PM ETJun 292 daysDandekar AtulCSBOSSale−7.50K$28.02−$210.2K−22.2%26.3K after10b5-1
Jun 24, 2026 (view filing)Jun 22-232 daysColoma Jason VChief Executive OfficerSSale−27.9K$26.04−$725.5K−8.0%319.1K after3 lots10b5-1
Jun 3, 2026 (view filing)Jun 12 daysBernstein HaroldPresident, R&D & CMOSSale−14.9K$25.66−$381.1K−100.0%0 after2 lots10b5-1
Jun 3, 2026 (view filing)Jun 12 daysColoma Jason VChief Executive OfficerSSale−6.64K$26.20−$174.1K−19.2%28.0K after2 lots10b5-1
Jun 2, 2026 (view filing)May 294 daysDandekar AtulCSBOSSale−7.50K$26.34−$197.6K−23.2%24.8K after10b5-1
May 27, 2026 (view filing)May 22-265 daysColoma Jason VChief Executive OfficerSSale−32.6K$26.02−$847.2K−8.5%351.0K after3 lots10b5-1
May 18, 2026 (view filing)May 144 daysBernstein HaroldPresident, R&D & CMOSSale−15.0K$26.22−$393.3K−100.0%0 after10b5-1
May 18, 2026 (view filing)May 153 daysColoma Jason VChief Executive OfficerSSale−1.94K$26.00−$50.4K−5.9%31.0K after2 lots10b5-1
May 1, 2026 (view filing)Apr 292 daysDandekar AtulCSBOSSale−7.50K$25.37−$190.3K−41.7%10.5K after10b5-1
Apr 2, 2026 (view filing)Apr 11 dayBachrodt AmySVP, FinanceSSale−2.50K$29.44−$73.6K−16.2%13.0K after2 lots10b5-1
Apr 2, 2026 (view filing)Apr 11 dayBernstein HaroldPresident, R&D & CMOSSale−15.0K$29.46−$441.9K−100.0%0 after3 lots10b5-1
Apr 1, 2026 (view filing)Mar 302 daysDandekar AtulCSBOSSale−7.50K$29.34−$220.1K−41.7%10.5K after2 lots10b5-1
Mar 20, 2026 (view filing)Mar 20Same dayBernstein HaroldPresident, R&D & CMOSSale−15.0K$49.10−$736.4K−100.0%0 after3 lots10b5-1
Mar 12, 2026 (view filing)Mar 102 daysBernstein HaroldPresident, R&D & CMOSSale−30.0K$50.46−$1.51M−100.0%0 after2 lots10b5-1
Mar 3, 2026 (view filing)Mar 21 dayBachrodt AmySVP, FinanceSSale−5.00K$45.20−$226.0K−27.8%13.0K after2 lots10b5-1
Mar 3, 2026 (view filing)Feb 274 daysDandekar AtulCSBOSSale−7.50K$45.43−$340.7K−41.7%10.5K after2 lots10b5-1
Feb 4, 2026 (view filing)Feb 22 daysBachrodt AmySVP, FinanceSSale−5.00K$46.04−$230.2K−27.8%13.0K after3 lots10b5-1
Feb 4, 2026 (view filing)Feb 22 daysBernstein HaroldPresident, R&D & CMOSSale−15.0K$46.02−$690.3K−100.0%0 after4 lots10b5-1
Feb 2, 2026 (view filing)Jan 294 daysDandekar AtulCSBOSSale−7.50K$44.26−$332.0K−41.7%10.5K after3 lots10b5-1
Jan 26, 2026 (view filing)Jan 224 daysBachrodt AmySVP, FinanceSSale−5.00K$45.52−$227.6K−27.8%13.0K after10b5-1
Jan 9, 2026 (view filing)Jan 72 daysBernstein HaroldPresident, R&D & CMOSSale−25.2K$40.20−$1.01M−100.0%0 after10b5-1
Jan 8, 2026 (view filing)Jan 6-72 daysSohn Catherine A.DirectorSSale−29.4K$39.07−$1.15M−100.0%0 after2 lots
Jan 6, 2026 (view filing)Jan 24 daysBachrodt AmySVP, FinanceSSale−5.00K$39.15−$195.8K−27.8%13.0K after2 lots10b5-1
Jan 6, 2026 (view filing)Jan 2-54 daysBernstein HaroldPresident, R&D & CMOSSale−4.84K$40.39−$195.7K−100.0%0 after2 lots10b5-1
Dec 31, 2025 (view filing)Dec 29-302 daysBachrodt AmySVP, FinanceSSale−15.0K$40.41−$606.2K−53.6%13.0K after3 lots10b5-1
Dec 31, 2025 (view filing)Dec 292 daysBernstein HaroldPresident, R&D & CMOSSale−45.0K$40.57−$1.83M−100.0%0 after2 lots10b5-1
Dec 31, 2025 (view filing)Dec 29-302 daysDandekar AtulCSBOSSale−72.5K$40.56−$2.94M−87.3%10.5K after3 lots10b5-1
Sep 16, 2025 (view filing)Sep 151 dayScheller Richard HDirectorSSale−20.7K$22.37−$464.0K−100.0%0 after